EUVIMEDEUVIMED entdecken
Scoping Review

Stem Cell–Derived Extracellular Vesicles for Chronic Limb-Threatening Ischemia: A Preclinical Scoping Review

Md. Mojahidur Hasan, Sehreen Tory, Yusuf Tutar

Journal of Critical Limb Ischemia · 2026-06 · 6 (2) · E51-E60

DOI: 10.25270/jcli/clig-2500012 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Critical Limb Ischemia, 2026-06. Verfasst von Md. Mojahidur Hasan und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic limb-threatening ischemia (CLTI) is a severe lower limb arterial obstructive disease that leads to a diminished quality of life and a higher risk of limb amputation. Currently, effective treatments are limited, and revascularization remains the primary focus of research. Stem cell–derived extracellular vesicles (EVs) have emerged as a promising therapeutic option for both ischemic and degenerative diseases. Notably, stem cell–derived EVs exhibit minimal tumorigenic and immunogenic risks, making them more advantageous than direct stem cell therapy. In this scoping review, Web of Science, PubMed, and Scopus databases were searched to find eligible articles. Studies were included if they evaluated the effects of stem cell–derived EVs in treating animal models of CLTI. Thirty articles were included. EVs isolated from diverse stem cell sources significantly improved blood flow, enhanced neovascularization and muscle regeneration, reduced tissue degeneration, and lowered the risk of necrosis and limb loss. These benefits mainly result from reducing inflammation, promoting angiogenesis, and delivering pro-angiogenic microRNAs. Additionally, engineered EVs demonstrated even greater therapeutic effects. Despite these promising preclinical results, further research is needed to determine optimal dosing, delivery routes, standardization of EVs, and long-term safety before clinical application in humans.

Zitieren

APA

Hasan, M. M., Tory, S., & Tutar, Y. (2026). Stem Cell–Derived Extracellular Vesicles for Chronic Limb-Threatening Ischemia: A Preclinical Scoping Review. Journal of Critical Limb Ischemia, 6(2), E51-E60. https://doi.org/10.25270/jcli/clig-2500012

Vancouver

Hasan MM, Tory S, Tutar Y. Stem Cell–Derived Extracellular Vesicles for Chronic Limb-Threatening Ischemia: A Preclinical Scoping Review. Journal of Critical Limb Ischemia. 2026;6(2):E51-E60. doi:10.25270/jcli/clig-2500012

BibTeX
@article{Hasan2026,
  author = {Hasan, Md. Mojahidur and Tory, Sehreen and Tutar, Yusuf},
  title = {Stem Cell–Derived Extracellular Vesicles for Chronic Limb-Threatening Ischemia: A Preclinical Scoping Review},
  journal = {Journal of Critical Limb Ischemia},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {E51--E60},
  doi = {10.25270/jcli/clig-2500012}
}
Kostenlos starten →